Quick Summary

Honeybush (Cyclopia intermedia) is a plant traditionally used as a herbal tea. Current scientific research on Honeybush itself is limited, with research status considered pending. Some related bioactive compounds, such as mangiferin found in some plants, have been investigated mainly in preclinical studies for potential anticancer and anti-inflammatory effects. Evidence directly from clinical trials or human studies on Honeybush is lacking.

What Is It?

Honeybush is a flowering plant native to South Africa, often prepared as a naturally sweet herbal tea. It belongs to the Cyclopia genus and is known for its distinctive honey-like aroma. The plant is sometimes used as a caffeine-free alternative to rooibos tea.

Traditional Uses

Traditionally, Honeybush tea has been consumed for its pleasant taste and aroma. It is commonly enjoyed as a herbal beverage and has been used in folk practices for general wellness. However, traditional medicinal claims are not well documented in modern scientific literature.

Active Compounds

Honeybush contains various phytochemicals, including polyphenols and flavonoids. Some related bioactive compounds identified in related plants include mangiferin, which has been studied for potential biological activities. Exact characterization of Honeybush’s active constituents and their effects in humans remain under investigation.

Potential Benefits with Evidence Levels

  • Anticancer: Insufficient clinical evidence. Preclinical research highlights natural compounds that may activate thermogenesis and modulate tumor metabolism, but no clinical trials on Honeybush have been identified. (Moon DO, 2026)
  • Anti-inflammatory: Preclinical and in vitro evidence. Phytochemicals including mangiferin show modulation of NF-κB pathways and inflammatory mediators in laboratory and animal models of inflammatory bowel diseases. Specific clinical trial data for Honeybush are not available. (Laurindo et al., 2023)

Side Effects

No clinical adverse effects or toxicity reports related to Honeybush have been found in the available research data. However, safety profile in humans remains unclear due to the lack of direct clinical safety data.

Drug Interactions

There is no information available on drug interactions involving Honeybush. Caution is advised when combining with medications until more data are available.

Who Should Avoid It

No specific contraindications have been reported or studied for Honeybush. Due to insufficient safety data, those who are pregnant, breastfeeding, or have underlying health conditions should exercise caution and consult a healthcare professional before use.

Evidence Limitations

The evidence on Honeybush is currently limited to preclinical and in vitro studies, often involving related phytochemicals rather than the plant itself. There is a notable lack of controlled human clinical trials or systematic reviews directly assessing Honeybush efficacy, safety, or pharmacology. The research status is classified as pending, indicating that more rigorous human research is needed before any clinical claims can be substantiated.

References

  • Moon DO. Natural Product Driven Activation of UCP1 and Tumor Metabolic Suppression: Integrating Thermogenic Nutrient Competition with Cancer Metabolic Reprogramming. Europe PMC. 2026. https://pubmed.ncbi.nlm.nih.gov/41594630/
  • Sarfraz M, Khan A, Batiha GE, Akhtar MF, Saleem A, Ajiboye BO, Kamal M, Ali A, Alotaibi NM, Aaghaz S, Siddique MI, Imran M. Nanotechnology-Based Drug Delivery Approaches of Mangiferin: Promises, Reality and Challenges in Cancer Chemotherapy. Europe PMC. 2023. https://pubmed.ncbi.nlm.nih.gov/37627222/
  • Laurindo LF, Santos AROD, Carvalho ACA, Bechara MD, Guiguer EL, Goulart RA, Vargas Sinatora R, Araújo AC, Barbalho SM. Phytochemicals and Regulation of NF-kB in Inflammatory Bowel Diseases: An Overview of In Vitro and In Vivo Effects. Europe PMC. 2023. https://pubmed.ncbi.nlm.nih.gov/36677021/
  • Rahman S, Sadaf S, Hoque ME, Mishra A, Mubarak NM, Malafaia G, Singh J. Unleashing the promise of emerging nanomaterials as a sustainable platform to mitigate antimicrobial resistance. Europe PMC. 2024. https://pubmed.ncbi.nlm.nih.gov/38694553/
  • Lautié E, Russo O, Ducrot P, Boutin JA. Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes. Europe PMC. 2020. https://pubmed.ncbi.nlm.nih.gov/32317969/

Last Reviewed

April 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. Honeybush has not been fully evaluated for safety or efficacy in humans. Consult a qualified healthcare provider before using any herbal products, especially if you are pregnant, breastfeeding, have pre-existing health conditions, or are taking medications.